FDA, Covid and vaccine
Digest more
Top News
Overview
Impacts
A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations provided by a rival drugmaker.
U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab—that is according to a new Senate report released by GOP Sen.
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from yesterday.
The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it will require another clinical trial.
Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click to find out why PFE stock is a Hold.